Research progress of microRNA in diagnosis and treatment of pancreatic cancer

doi:10.3760/cma.j.issn.1673-422X.2014.11.012

Abstract

Abstract: MicroRNA (miRNA) plays a regulating function in translation stage of gene expression. MiRNA has been found directly involving in the occurrence and development of pancreatic cancer, and its abnormal expression is closely related to early diagnosis of pancreatic cancer and may provide new therapeutic target for pancreatic cancer patients. MiRNA detection will have good application prospect in on the diagnosis and treatment of pancreatic cancer.

Key words: Pancreatic neoplasms, MicroRNAs, Diagnosis, Treatment

MENG Qing-Cai, GU Hong-Chen, HUANG Xin-Yu. Research progress of microRNA in diagnosis and treatment of pancreatic cancer[J]. Journal of International Oncology, 2014, 41(11): 837-840.

References

［1］ Ferlay J, SteliarovaFoucher E, LortetTieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012［J］. Eur J Cancer, 2013, 49(6):13741403. ［2］ Hidalgo M. Pancreatic cancer［J］. N Engl J Med, 2010, 362(17):16051617. ［3］ Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013［J］. CA Cancer J Clin, 2013, 63(1):1130. ［4］ Bauer AS, Keller A, Costello E, et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue［J］. PLoS One, 2012, 7(4):e34151. ［5］ Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis［J］. JAMA, 2007, 297(17):19011908. ［6］ Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma［J］. Mod Pathol, 2012, 25(12):16091622. ［7］ Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer［J］. J Pathol, 2011, 223(2):102115. ［8］ Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact［J］. J Clin Oncol, 2009, 27(34):58485856. ［9］ Ambros V. The functions of animal microRNAs［J］. Nature, 2004, 431(7006):350355. ［10］ Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function［J］. Cell, 2004, 116(2):281297. ［11］ Giovinazzo F, Turri G, Zanini S, et al. Clinical implications of biological markers in pancreatic ductal adenocarcinoma［J］. Surg Oncol, 2012, 21(4):e171182. ［12］ Kaur S, Baine MJ, Jain M, et al. Early diagnosis of pancreatic cancer: challenges and new developments［J］. Biomark Med, 2012, 6(5):597612. ［13］ Panarelli NC, Chen YT, Zhou XK, et al. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma［J］. Pancreas, 2012, 41(5):685690. ［14］ Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by realtime PCR analysis［J］. World J Surg, 2009, 33(4):698709. ［15］ Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases［J］. Cell Res, 2008, 18(10):9971006. ［16］ Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel bloodbased biomarkers of disease［J］. Cancer Prev Res, 2009, 2(9):807813. ［17］ Ali S, Almhanna K, Chen W, et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer［J］. Am J Transl Res, 2010, 3(1):2847. ［18］ Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA199 for early detection of pancreatic cancer［J］. Int J Cancer, 2012, 131(3):683691. ［19］ Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer［J］. Clin Chem, 2012, 58(3):610618. ［20］ Sadakari Y, Ohtsuka T, Ohuchida K, et al. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma［J］. JOP, 2010, 11(6): 587592. ［21］ Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer［J］. JAMA, 2014, 311(4): 392404. ［22］ Wang WS, Liu LX, Li GP, et al. Combined serum CA199 and miR27a3p in peripheral blood mononuclear cells to diagnose pancreatic cancer［J］. Cancer Prev Res, 2013, 6(4):331338. ［23］ Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses［J］. Science, 2008, 321(5897):18011806. ［24］ Mahadevan D, Chalasani P, Rensvold D, et al. Phase Ⅰ trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma［J］. Am J Clin Oncol, 2013, 36(3):239243. ［25］ Parasramka MA, Ali S, Banerjee S, et al. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures［J］. Mol Nutr Food Res, 2013, 57(2):235248. ［26］ Ji Q, Hao X, Zhang M, et al. MicroRNA miR34 inhibits human pancreatic cancer tumorinitiating cells［J］. PLoS One, 2009, 4(8):e6816. ［27］ Pramanik D, Campbell NR, Karikari C, et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice［J］. Mol Cancer Ther, 2011, 10(8):14701480.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[5]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng. Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor [J]. Journal of International Oncology, 2024, 51(5): 298-302.
[6]	Wang Kun, Zhou Zhongxin, Zang Qiwei. Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection [J]. Journal of International Oncology, 2024, 51(4): 198-203.
[7]	Yan Aiting, Wang Cuizhu, Liu Chungui, Lu Xiaomin. Clinical efficacy and safety of camrelizumab and sintilimab in the treatment of advanced non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 137-142.
[8]	Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng. Imaging diagnosis， pathological upgrade， and imaging technology progress of ductal carcinoma in situ of the breast [J]. Journal of International Oncology, 2024, 51(3): 166-169.
[9]	Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185.
[10]	Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190.
[11]	Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie. Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(2): 89-94.
[12]	Jin Xudong, Chen Zhongjian, Mao Weimin. Research progress on the role of MTAP in malignant mesothelioma [J]. Journal of International Oncology, 2024, 51(2): 99-104.
[13]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[14]	Huang Zhen, Chen Yongshun. Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma [J]. Journal of International Oncology, 2024, 51(1): 59-64.
[15]	Wang Jing, Xu Wenting. Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm [J]. Journal of International Oncology, 2023, 50(9): 520-526.